Skip to main content

Epithalon (10mg Vial) Dosage Protocol

Epithalon is a synthetic peptide that may support anti-aging by regulating telomere length and promoting cellular longevity.

  • Reconstitute (Standard): Add 2.0 mL bacteriostatic water → 5 mg/mL; 5 mg dose = 1.0 mL (100 units).

  • Reconstitute (Advanced): Add 1.0 mL bacteriostatic water → 10 mg/mL; 10 mg dose = 1.0 mL (100 units).

  • Typical daily range: 5–10 mg once daily for 10–20 consecutive days.

  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and weekly dosing

Standard Approach (2 mL Reconstitution = 5 mg/mL)

Each 10 mg vial provides 2 doses at this concentration.

Week

Daily Dose (mcg each)

Units (per injection) (mL)

Days 1–10 (Standard Cycle)

5 mg

100 units (1.0 mL)

Days 1–20 (Extended Cycle)

5 mg

100 units (1.0 mL)

Standard Reconstitution Steps

  1. Allow the vial to reach room temperature before opening to reduce condensation uptake.

  2. Draw 2.0 mL bacteriostatic water with a sterile syringe.

  3. Inject slowly down the vial wall; avoid foaming.

  4. Gently swirl/roll until dissolved (do not shake vigorously).

  5. Label with date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Advanced Approach (1 mL Reconstitution = 10 mg/mL)

Each 10 mg vial provides 1 dose at this concentration—one vial, one injection.

Phase

Daily Dose (mg)

Units (per injection) (mL)

Days 1–10 (Higher Dose)

10 mg

100 units (1.0 mL)

Advanced Reconstitution Steps

  1. Allow the vial to reach room temperature before opening to reduce condensation uptake.

  2. Draw 1.0 mL bacteriostatic water with a sterile syringe.

  3. Inject slowly down the vial wall; avoid foaming.

  4. Gently swirl/roll until dissolved (do not shake vigorously).

  5. Inject entire contents (100 units / 1.0 mL) subcutaneously; discard vial after single use.

Frequency: Inject once daily subcutaneously. Some clinicians recommend evening dosing (near bedtime) to potentially leverage effects on pineal activity and nocturnal melatonin release. Cycles are typically repeated 1–2 times per year, separated by 4–6+ months off-periods.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on a 10–20 day cycle at 5 mg/day (Standard) or 10 mg/day (Advanced).

    • Standard (5 mg/day): 10-day cycle ≈ 5 vials (each vial = 2 doses)

    • Standard (5 mg/day): 20-day cycle ≈ 10 vials

    • Advanced (10 mg/day): 10-day cycle ≈ 10 vials (each vial = 1 dose)

    • 10-day cycle: 10 syringes (1 per day)

    • 20-day cycle: 20 syringes

    • Standard (2 mL per vial): 5 vials = 10 mL ; 10 vials = 20 mL

    • Advanced (1 mL per vial): 10 vials = 10 mL

  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

    • 10-day cycle: 20 swabs

    • 20-day cycle: 40 swabs

Protocol Overview

Concise summary of the cyclic short-term regimen.

  • Goal: Support telomere maintenance, circadian rhythm normalization, and cellular antioxidant capacity.

  • Schedule: Daily subcutaneous injections for 10–20 consecutive days, repeated 1–2× per year.

  • Dose Range: 5–10 mg daily (50–100 mg total per cycle).

  • Reconstitution: Standard: 2.0 mL per vial (5 mg/mL); Advanced: 1.0 mL per vial (10 mg/mL).

  • Off-Period: 4–6+ months between cycles to allow sustained effects.

Dosing Protocol

Evidence-based cyclic approach.

  • Standard: 5 mg once daily for 10–20 days.

  • Advanced: 10 mg once daily for 10 days (split into two injections).

  • Frequency: Once per day (subcutaneous).

  • Cycle Length: 10–20 days; repeat annually or biannually.

  • Timing: Evening administration may be preferred; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) for long-term; 2–8 °C (35.6–46.4 °F) acceptable for 1–2 months.

  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 7 days for optimal stability.

  • Allow vials to reach room temperature before opening to reduce condensation uptake.

  • Multi-dose vials: Discard 28 days after first puncture per CDC guidelines.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes (28–31 gauge, 5/16″–5/8″ needle); dispose in a sharps container.

  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.

  • Inject slowly; wait a few seconds before withdrawing the needle.

  • Document daily dose, time, and site rotation to maintain consistency.

  • Never reuse syringes or needles.

How This Works

Epitalon’s primary proposed mechanism involves telomerase activation in cells. By upregulating telomerase, Epitalon may elongate telomeres—the protective end-caps of chromosomes that typically shorten with cell divisions and aging. In vitro experiments on human cells showed Epitalon induced telomerase and increased telomere length by approximately 30%. Epitalon also influences the pineal gland and circadian regulators: it restores melatonin secretion in aged organisms by modulating key clock genes in the suprachiasmatic nucleus. Human trials demonstrated that 20 days of Epitalon increased endogenous melatonin production 1.6-fold and favorably shifted circadian gene expression toward a more youthful profile. Additionally, Epitalon may enhance antioxidant defenses (superoxide dismutase, glutathione peroxidase) and reduce oxidative damage in aging tissues.

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Telomere maintenance: Supports telomerase activation and may extend cellular replicative capacity beyond normal limits.

  • Melatonin normalization: Restores nocturnal melatonin output and improves sleep quality in elderly populations.

  • Longevity signals: Long-term human studies reported reduced overall mortality (approximately 28% lower) in treated elderly cardiac patients over 12-year follow-up.

  • Antioxidant support: Enhances endogenous antioxidant enzyme activities.

  • Vision support: Preliminary studies in retinitis pigmentosa showed functional improvements in 90% of treated cases.

  • Side effects: Generally well tolerated in clinical studies; occasional mild injection-site reactions (redness, minor discomfort) may occur.

Lifestyle Factors

Complementary strategies for best outcomes.

  • Maintain consistent sleep–wake schedules to support circadian rhythm benefits.

  • Prioritize sleep hygiene and minimize blue light exposure before bed.

  • Pair with a balanced, antioxidant-rich diet (colorful vegetables, healthy fats).

  • Combine regular physical activity (resistance and aerobic) to reinforce cellular adaptations.

  • Manage stress through mindfulness or relaxation practices.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Clean the vial stopper and skin with alcohol; allow to dry.

  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.

  • Do not aspirate for subcutaneous injections; inject slowly and steadily.

  • Rotate sites systematically (abdomen at least 2 inches from navel, anterolateral thighs, upper outer triceps area) to avoid lipohypertrophy.

  • Withdraw needle gently; apply light pressure with gauze if needed.

  • Dispose of syringe immediately in sharps container—never recap needles.

Did this answer your question?